An international team of researchers used liquid gallium to create an antiviral and antimicrobial coating and tested it on a range of fabrics, including facemasks. The coating adhered more strongly to fabric than some conventional metal coatings, and eradicated 99% of several common pathogens within five minutes.
Read More
BioCryst Pharmaceuticals of Durham has begun a Phase 1 clinical trial of an anti-viral drug for treating two serious viral infections, Marburg virus disease and yellow fever.
Read More
Grifols has received approval from the U.S. FDAfor a new formulation of GamaSTAN, its medicine for treating patients who’ve been exposed to the hepatitis A and measles viruses.
Read More
Chimerix, a Durham-based biopharmaceutical company that’s developing novel antiviral medicines for unmet medical needs,, is reporting progress on two fronts.
Read MoreBiopharmaceutical company Chimerix Inc. will give raises to four executive officers, including its CEO and chief medical officer, for 2018, along with bonuses for the previous year’s performance.
Read More
